社区药房的心理健康评估 - 一项跨部门研究
Mónica Condinho1,2,3, Isabel Ramalhinho2,3, Catarina Vaz-Velho4
1AcF-Acompanhamento Farmacoterapêutico, Lda., 7490-324 Pavia, Portugal.
Pharmacy (Basel, Switzerland)
|June 26, 2024
概括
社区药剂师可以识别未被诊断的焦虑和抑郁症. 许多被诊断的患者也表现出无法控制的症状,强调需要更好的监测和药剂师参与精神卫生保健的需要.
科学领域:
- 公共卫生 公共卫生
- 心理健康服务 心理健康服务
- 社区药房实践 社区药房实践
背景情况:
- 葡萄牙的焦虑和抑郁症患病率很高.
- 社区药剂师处于战略地位,能够发现心理健康问题并监督患者的治疗.
- 现有的查方法和监测协议需要在社区药房设置中进行评估.
研究的目的:
- 为了选没有诊断的个人,以寻找焦虑和抑郁症状.
- 监测已经被诊断患有焦虑和抑郁症的患者的病情.
- 评估社区药剂师在心理健康查和监测中的作用.
主要方法:
- 在社区药房用户中进行了一项观察性,横截面研究.
- 症状评估使用了通用焦虑障碍-7 (GAD-7) 和患者健康问卷-9 (PHQ-9).
- 在2020年9月至2021年7月期间,从591名参与者收集了数据.
主要成果:
- 在未被诊断的参与者中,18.2% (GAD-7) 和12.1% (PHQ-9) 呈现中度至重度症状.
- 在被诊断的患者中,有39.4%的焦虑症患者和49.5%的抑郁症患者有不受控制的症状.
- 焦虑症状在男性和不服用药物的患者中较低;抑郁症症状在女性,受教育程度较低,独自生活或服用特定药物的患者中更为普遍.
结论:
- 在社区药房中,大量未经诊断的个人表现出临床相关的焦虑和抑郁症状.
- 在被诊断出患有焦虑和抑郁症的患者中,很大一部分患者无法控制焦虑和抑郁症.
- 这些发现强调了药剂师在识别有风险的个体和改善诊断精神健康状况的监测方面发挥的关键作用.
更多相关视频
07:31Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
7.1K
10:17High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
Published on: April 23, 2019
9.6K
相关概念视频
Community Based Intervention
38
Community-based interventions in mental health represent a paradigm shift from institution-centered care to treatments embedded within the fabric of local communities. By prioritizing inclusion and leveraging existing societal structures, this approach fosters a supportive environment conducive to addressing mental health challenges while promoting individual dignity and agency.
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
38
Psychosis: Goals of Pharmacotherapy
119
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
119
Pharmacovigilance
817
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
817
Drug Therapy
41
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
41
Nursing Evaluation
3.3K
The evaluation stage signals the end of the nursing process. The nurse gathers evaluative data to assess whether or not the patient has attained the expected results. Whereas the nurse collects data in the nursing assessment to identify the patient's health concerns, the evaluation stage data determines if the indicated health issues are resolved. Evaluative data collection includes two sections: the data acquired to evaluate patient outcomes and the time criteria for data collection.
3.3K
Analysis of Population Pharmacokinetic Data
252
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
252
